On Monday, Neumora Therapeutics Inc (NASDAQ: NMRA) opened lower -6.22% from the last session, before settling in for the closing price of $2.09. Price fluctuations for NMRA have ranged from $0.61 to $11.57 over the past 52 weeks.
Company’s average yearly earnings per share was noted 6.66% at the time writing. With a float of $57.94 million, this company’s outstanding shares have now reached $161.95 million.
Neumora Therapeutics Inc (NMRA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Neumora Therapeutics Inc is 65.32%, while institutional ownership is 18.66%. The most recent insider transaction that took place on Nov 11 ’25, was worth 307,026. In this transaction an insider of this company sold 114,703 shares at a rate of $2.68, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Director proposed sale 114,703 for $2.68, making the entire transaction worth $307,027.
Neumora Therapeutics Inc (NMRA) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.37 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.44) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.66% per share during the next fiscal year.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Check out the current performance indicators for Neumora Therapeutics Inc (NMRA). In the past quarter, the stock posted a quick ratio of 6.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
Analysing the last 5-days average volume posted by the [Neumora Therapeutics Inc, NMRA], we can find that recorded value of 0.65 million was lower than the volume posted last year of 1.81 million. As of the previous 9 days, the stock’s Stochastic %D was 13.02%.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 30.65%, which indicates a significant increase from 6.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.14 in the past 14 days, which was lower than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.30, while its 200-day Moving Average is $1.49. Now, the first resistance to watch is $2.05. This is followed by the second major resistance level at $2.14. The third major resistance level sits at $2.20. If the price goes on to break the first support level at $1.89, it is likely to go to the next support level at $1.83. Should the price break the second support level, the third support level stands at $1.74.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
There are currently 167,089K shares outstanding in the company with a market cap of 327.50 million. Presently, the company’s annual sales total 0 K according to its annual income of -243,790 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -56,760 K.
